Omicron & other variants: Global regulators agreed that the administration of multiple booster doses at short intervals would not be sustainable in the long term. #COVID19#EMAPresser#ICMRA
Repeated administration of #COVID19#boosters with very short intervals might reduce the level of antibodies that can be produced at each administration. #EMAPresser
In the future, if it turns out we need to re-vaccinate, #COVID19vaccines could be offered at the arrival of the cold season, as done for the flu. This would increase the antibody response when we most need it. #EMAPresser
EMA has not yet seen data on the 4th dose. Currently, there is no evidence for the need of a 4th dose in the general population with the current #COVID19vaccines. #EMAPresser
In people with severely weakened immune systems, who have received 3 doses for primary vaccination, it would be reasonable for public health authorities to consider the administration of a 4th dose of #COVID19vaccines. #EMAPresser
Approval of #COVID19vaccines with a different composition requires clinical data that show a superior immune response than the one generated by the #boosters currently available. #EMAPresser
There is a need for a long-term strategy on the types of vaccines needed to manage #COVID19. This is an ongoing global discussion at the crossroads of science and public policy and needs collaboration among public health decision-makers at all levels. #EMAPresser.
An EMA review of scientific studies found no sign of an increased risk of #pregnancy complications, miscarriages, preterm births or adverse effects in the unborn babies following mRNA #COVID19 vaccination. #EMAPresser
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Don’t miss our tweets during the press briefing. Follow #EMAPresser.
EMA concluded that 3rd doses of #Comirnaty and #Spikevax may be given to people with severely weakened immune systems aged 12 or older, at least 28 days after their second dose. #EMAPresser
Currently approved #COVID19vaccines protect from the most acute consequence of this disease: hospitalisation and death. As many people as possible should be fully vaccinated. #EMAPresser
The evidence is becoming clearer on the need to consider additional vaccine doses for people who may poorly respond to #COVID19 vaccination, such as those with severely weakened immune systems or some elderly patients. #EMAPresser